AbbVie pulls the trigger on a Covid-19 antibody, going all in on a drug discovered by research alliance

With multiple repurposed Covid-19 treatments already in the clinic (and one that flunked out), AbbVie is placing its next bet on something new: an experimental antibody it spent the last several months developing with Harbour BioMed, the Netherlands’ Utrecht University and Erasmus Medical Center.